-
公开(公告)号:AU2005229698A1
公开(公告)日:2006-05-18
申请号:AU2005229698
申请日:2005-11-03
Applicant: SERVIER LAB
Inventor: LESTAGE PIERRE , CORDI ALEXIS , DESOS PATRICE
IPC: C07D285/24 , A61K31/549 , A61P25/08 , A61P25/18 , A61P25/24 , A61P25/28
Abstract: Benzothiadiazine compounds (I) and their enantiomers, diastereoisomers and addition salts with an acid or base are new. Benzothiadiazine compounds of formula (I) and their enantiomers, diastereoisomers and addition salts with an acid or base are new. R 11-6C alkyl substituted by halo(s); R 2H, halo or OH; R 3aryl (optionally substituted by 1-6C alkyl(s)), 1-6C polyhaloalkyl, halo, 1-6C alkoxy-carbonyl, 1-6C alkylthio, carboxy, 1-6C acyl, 1-6C (polyhalo)alkoxy, OH, CN, nitro, amidino (optionally substituted by 1 or 2 1-6C alkyl, OH, 1-6C alkoxy or -O-(C(=O))-R 12), amino (optionally substituted by 1 or 2 1-6C alkyl), aminocarbonyl (optionally substituted by 1 or 2 1-6C alkyl), benzyloxy, 1-6C alkylsulfonylamino (optionally substituted on the N by 1-6C alkyl), trifluoromethylsulfonylamino, heterocyclic or 1-6C alkyl (substituted by halo, 1-6C alkyl, NR 4R 5, S(O) nR 6, OR 7, amidino (optionally substituted by 1 or 2 1-6C alkyl, OH, 1-6C alkoxy or -O-(C=O)-R 12) and/or heterocyclic); R 4H, 1-6C alkyl, S(O) pR 8, COR 9 or P(O)(OR 10)(OR 11); and R 5H or 1-6C alkyl; or NR 4R 5heterocyclic; R 6, R 8-R 12H, 1-6C alkyl (optionally substituted by halo(s)), aryl-(1-6C alkyl) or aryl; R 71-6C alkyl or 1-6C acyl; and n, p : 0-2. [Image] ACTIVITY : Nootropic; Tranquilizer; Antidepressant; Neuroprotective; Cerebroprotective; Anticonvulsant; Neuroleptic; Vasotropic. MECHANISM OF ACTION : Alpha-amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid (AMPA) modulator. The ability of (I) to modulate AMPA was assessed using rats. The results showed that N-(4-{[4-(2-bromoethyl)-1,1-dioxido-3,4-dihydro-2H-1,2,4-benzothiadiazin-7-yl]oxy}benzyl)methanesulfonamide exhibited an EC2X value of 0.04 mu M.
-
公开(公告)号:FR2877338A1
公开(公告)日:2006-05-05
申请号:FR0411690
申请日:2004-11-03
Applicant: SERVIER LAB
Inventor: DESOS PATRICE , CORDI ALEXIS , LESTAGE PIERRE
IPC: C07D285/24 , A61K31/549 , A61P9/10 , A61P25/08 , A61P25/14 , A61P25/18 , A61P25/22 , A61P25/24 , A61P25/28
Abstract: Composés de formule (I) :dans laquelle :R1 représente un alkyle substitué par un ou plusieurs atomes d'halogène,R2 représente hydrogène, halogène ou OH,R3 représente un groupement aryle non substitué ou substitué leurs isomères ainsi que leurs sels d'addition.Médicaments.
-
53.
公开(公告)号:CY1113914T1
公开(公告)日:2016-07-27
申请号:CY131100282
申请日:2013-04-04
Applicant: SERVIER LAB
Inventor: ORTUNO JEAN-CLAUDE , CORDI ALEXIS , LACOSTE JEAN-MICHEL , FEJES IMRE , BURBRIDGE MICHAEL , HICKMAN JOHN , PIERRE ALAIN
IPC: C07D401/12 , A61K31/404 , A61P35/00 , C07D401/14 , C07D403/12 , C07D403/14 , C07D413/14 , C07D417/14
Abstract: Ενώσειςτουτύπου (I):
-
54.
公开(公告)号:BRPI0822066A2
公开(公告)日:2015-09-22
申请号:BRPI0822066
申请日:2008-12-10
Applicant: SERVIER LAB
Inventor: CORDI ALEXIS , COURCHAY CHRISTINE , HABERKORN LAURE , SIMONET SERGE , VERBEUREN TONY
IPC: C07D209/08 , A61K31/404
-
公开(公告)号:AU2010203305B2
公开(公告)日:2015-02-05
申请号:AU2010203305
申请日:2010-07-23
Applicant: SERVIER LAB
Inventor: ORTUNO JEAN-CLAUDE , CORDI ALEXIS , LACOSTE JEAN-MICHEL , FEJES IMRE , BURBRIDGE MICHAEL , HICKMAN JOHN , PIERRE ALAIN
IPC: C07D417/14 , A61K31/4045 , A61P35/00 , C07D403/14 , C07D413/14
Abstract: Compounds of formula (I): X R4 N RS I ( ) wherein: * m and n represent 1 or 2, * A represents a pyrrolyl group, * X represents a C(O), S(O) or SO 2 group, + R and R2 represent an alkyl group or, together with the nitrogen atom carrying them, form a heterocyclic group, + R3 and R4, together with the atoms carrying them, form a heterocyclic group, + R5 represents a hydrogen atom or an alkyl group, + R represents a hydrogen atom or a halogen atom. The compounds are used in pharmaceutical compositions and in the preparation of medicaments for use in the treatment of cancer.
-
公开(公告)号:CA2752131C
公开(公告)日:2014-04-22
申请号:CA2752131
申请日:2011-09-07
Applicant: SERVIER LAB
Inventor: CORDI ALEXIS , DESOS PATRICE , LESTAGE PIERRE , DANOBER LAURENCE
IPC: C07D419/12 , A61K31/554 , A61P25/00 , C07D291/08
Abstract: La présente invention concerne les composés de formule (I) : (voir formula I) leurs énantiomères et leurs diastéréoisomères, ainsi que leurs sels d'addition avec un acide ou une base pharmaceutiquement acceptable, dans laquelle R1 représente un atome d'hydrogène, un groupement hétérocyclique, cyano, alkoxycarbonyle, alkylsulfonylaminoalkyle, ou N-hydroxycarboximidamide. L'invention concerne également le procédé de préparation de ces composés, les compositions pharmaceutiques qui les contiennent ainsi que leur utilisation en tant que modulateur des récepteurs AMPA.
-
57.
公开(公告)号:ME01491B
公开(公告)日:2014-04-20
申请号:MEP3313
申请日:2010-08-03
Applicant: SERVIER LAB
Inventor: ORTUNO JEAN-CLAUDE , LACOSTE JEAN-MICHEL , FEJES IMRE , BURBRIDGE MICHAEL , HICKMAN JOHN , PIERRE ALAIN , CORDI ALEXIS
IPC: A61K31/404 , A61P35/00 , C07D401/12 , C07D401/14 , C07D403/12 , C07D403/14 , C07D413/14 , C07D417/14
-
公开(公告)号:PE20131342A1
公开(公告)日:2013-11-28
申请号:PE2013000377
申请日:2011-09-15
Applicant: SERVIER LAB
Inventor: CORDI ALEXIS , LESTAGE PIERRE , DESOS PATRICE , DANOBER LAURENCE
IPC: A61K31/551 , A61P25/00 , C07D291/08
Abstract: SE REFIERE A COMPUESTOS DERIVADOS DE DIHIDROBENZOXATIAZEPINA DE FORMULA (I) DONDE R1 ES H, CN, ALCOXICARBONILO(C1-C6), ALQUIL(C1-C6)SULFONILAMINOALQUILO(C1-C6), N-HIDROXICARBOXIMIDAMIDA O UN HETEROCICLICO TAL COMO PIRAZOLILO, TIAZOLILO, OXADIAZOLILO, ENTRE OTROS. SON COMPUESTOS PREFERIDOS: 8-[3-(5-METIL-1,2,4-OXADIAZOL-3-IL)FENOXI]-3,4-DIHIDRO-2H-5,1,2-BENZOXATIAZEPINA 1,1-DIOXIDO; 8-[3-(3-METIL-1,2,4-OXADIAZOL-5-IL)FENOXI]-3,4-DIHIDRO-2H-5,1,2-BENZOXATIAZEPINA 1,1-DIOXIDO; ENTRE OTROS. TAMBIEN SE REFIERE A UN PROCEDIMIENTO DE PREPARACION Y A UNA COMPOSICION FARMACEUTICA. DICHOS COMPUESTOS SON MODULADORES DE LOS RECEPTORES AMPA (ACIDO ALFA-AMINO-3-HIDROXI-5-METIL-4-ISOXAZOL-PROPIONICO) SIENDO UTILES EN EL TRATAMIENTO DE TRASTORNOS MNEMOCOGNITIVOS ASOCIADOS A LA EDAD, A LAS ENFERMEDADES NEURODEGENERATIVAS PROGRESIVAS, A LA ENFERMEDAD DE ALZHEIMER
-
公开(公告)号:RS52835B
公开(公告)日:2013-10-31
申请号:RSP20130274
申请日:2011-09-15
Applicant: SERVIER LAB
Inventor: LESTAGE PIERRE , DANOBER LAURENCE , CORDI ALEXIS , DESOS PATRICE
IPC: C07D291/08 , A61K31/551 , A61P25/00
Abstract: Phenoxy-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepine-dioxide compounds (I) and their enantiomers and diastereoisomers, and addition salts with an acid or a base, are new. Phenoxy-3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepine-dioxide compounds of formula (I) and their enantiomers and diastereoisomers, and addition salts with an acid or a base, are new. R1 = H, CN, 1-6C alkoxycarbonyl group, 1-6C alkylsulfonylamino1-6C alkyl group or N-hydroxy carboximidamide group, where the heterocyclic group is a 5-membered monocyclic aryl group containing 1-4 heteroatoms of N, O or S, the heterocyclic group is optionally substituted by one or more 1-6C alkyl or polyhalo-1-6C-alkyl group. Independent claims are included for: (1) the preparation of (I); and (2) 3,4-dihydro-2H-benzo[b][1,4,5]oxathiazepine-1,1-dioxide compound of formula (V). Hal = halo such as fluorine, chlorine or bromine. [Image] [Image] ACTIVITY : Nootropic; Tranquilizer; Antidepressant; Neuroprotective; Antiparkinsonian; Cerebroprotective; Anticonvulsant; Antialcoholic; Neuroleptic; Vasotropic. MECHANISM OF ACTION : Alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor modulator. Tests details are described but no results given.
-
公开(公告)号:ES2421504T3
公开(公告)日:2013-09-03
申请号:ES11290413
申请日:2011-09-15
Applicant: SERVIER LAB
Inventor: CORDI ALEXIS , DESOS PATRICE , LESTAGE PIERRE , DANOBER LAURENCE
IPC: C07D291/08 , A61K31/551 , A61P25/00
Abstract: Compuestos de fórmula (I): **Fórmula** donde R1 representa un átomo de hidrógeno, un grupo ciano, un grupo alcoxicarbonilo(C 1-C6) lineal o ramificado, un grupo alquil(C1-C6)-sulfonilaminoalquilo(C1-C6) lineal o ramificado, un grupo N-hidroxicarboximidamida o un grupo heterocíclico, sus enantiómeros y sus diastereoisómeros, así como sus sales de adición a un ácido o una base farmacéuticamente aceptables, entendiéndose por el concepto "grupo heterocíclico" un grupo aromático monocíclico de 5 miembros que contiene de uno a cuatro heteroátomos, idénticos o diferentes, seleccionados entre nitrógeno, oxígeno y azufre, pudiendo dicho grupo heterocíclico estar sustituido en caso dado con uno o más sustituyentes, iguales o diferentes, seleccionados entre alquilo(C1-C6) lineal o ramificado o polihaloalquilo(C1-C6) lineal o ramificado.
-
-
-
-
-
-
-
-
-